Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32 (Dealroom.co)

Faro, a company that builds data models and AI tools to accelerate clinical trials, secured a $37.3 million Series B financing round. The round was co-led by Merck Global Health Innovation Fund and venture firm S32, providing capital to expand Faro’s AI-driven trial-optimization platform.